Monoclonal antibodies were a key tool in the early pandemic response, but are now ineffective against new variants — putting immunocompromised patients at risk. Thanks for listening to WIRED. Check back in tomorrow to hear more stories from WIRED.com.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Fler avsnitt av What's New
Visa alla avsnitt av What's NewWhat's New med WIRED finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.